title: [Chronic radiodermatitis after a transjugular intrahepatic portosystemic shunt].
authors.forename: V
authors.initials: V
authors.lastname: Cante
authors.forename: M-S
authors.initials: MS
authors.lastname: Doutre
mesh_terms: D000328:Adult; D016736:Antiphospholipid Syndrome / Q000150:complications / Q000276:immunology; D006502:Budd-Chiari Syndrome / Q000209:etiology / Q000601:surgery; D002908:Chronic Disease; D003082:Colectomy; D017091:Colitis, Ischemic / Q000209:etiology / Q000601:surgery; D004307:Dose-Response Relationship, Radiation; D005260:Female; D005471:Fluoroscopy / Q000009:adverse effects*; D006801:Humans; D042965:Methylenetetrahydrofolate Reductase (NADPH2) / Q000235:genetics; D011169:Portal Vein; D019168:Portasystemic Shunt, Transjugular Intrahepatic; D011183:Postoperative Complications / Q000209:etiology* / Q000473:pathology; D011855:Radiodermatitis / Q000209:etiology* / Q000473:pathology; D015641:Radiography, Interventional / Q000009:adverse effects*; D012086:Reoperation; D015912:Thrombolytic Therapy; D013997:Time Factors; D020246:Venous Thrombosis / Q000188:drug therapy / Q000209:etiology
chemical_list: D042965:Methylenetetrahydrofolate Reductase (NADPH2)